This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Virginia Patent Foundation. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Kun Yuan: Innovator in Sulfur-Heterocycle Exchange Chemistry
Introduction
Kun Yuan is a prominent inventor based in Charlottesville, VA (US). He has made significant contributions to the field of chemistry, particularly in the area of sulfur-heterocycle exchange chemistry. His innovative work has implications for protein modification and identification of reactive amino acid residues.
Latest Patents
Kun Yuan holds a patent for "Sulfur-heterocycle exchange chemistry and uses thereof." This patent describes sulfonyl-triazole compounds and related sulfonyl-heterocycle compounds. These compounds can be utilized to identify reactive nucleophilic amino acid residues, such as reactive tyrosines and reactive lysines, in proteins. Furthermore, they can modify the activity of proteins with these reactive residues through the formation of protein adducts comprising a fragment of the compounds. The patent also outlines methods for screening these compounds to identify ligands of proteins containing a reactive lysine or a reactive tyrosine.
Career Highlights
Kun Yuan is affiliated with the University of Virginia, where he continues to advance research in his field. His work has garnered attention for its potential applications in biochemistry and molecular biology.
Collaborations
He has collaborated with notable colleagues, including Ku-Lung Hsu and Heung Sik Hahm, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Kun Yuan's contributions to sulfur-heterocycle exchange chemistry exemplify the impact of innovative research on the understanding and manipulation of protein functions. His work not only enhances scientific knowledge but also opens new avenues for therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
